UnitedHealth Group stock plunged on rising medical costs, leadership shifts, and a DOJ probe, plus 2025 guidance withdrawal.

Markets this week will focus on PCE inflation data, Fed minutes, and key earnings from NVIDIA and Salesforce, with economic ...

Stock and bond investors are fumbling in the fog of the U.S. budget deficit, the dollar and how to trade the Trump administration's tax bill, which passed the House early Thursday. Yet for Keith ...

Reacting to the Q3 FY25 results, TD Cowen analyst Shaul Eyal reiterated a buy rating on Palo Alto stock with a price target ...

Coforge (₹8,266*) has announced a share split with a ratio of 5:1. So, the adjustment factor will be 5. The split will lead ...

The spotlight was back on U.S. supply chains heading into the Memorial Day weekend after President Donald Trump threatened a "straight" 50% tariff on the European Union and at least a 25% levy on ...

The market is uncertain, with neither stocks nor bonds offering safety, but opportunity remains. Learn how income investors ...

Indian equities are poised for a week influenced by domestic macroeconomic data, global cues, and foreign investor activity.

It seems far too easy to blame the president for the stock market’s bad week. It wasn’t President Trump who rushed in to buy ...

As noted, AGNC Investment is a mortgage REIT, a subsector of the REIT category that operates in a completely different ...

PCE inflation data; first-quarter GDP update; Fed representatives speaking; consumer confidence; earnings from Nvidia, ...

Emkay's latest report on Oil India highlights a 'BUY' rating with a revised target price of Rs495, emphasizing key financial insights and production metrics from Q4FY25.